ST-067 and Teclistamab for the Treatment of Relapsed or Refractory Multiple Myeloma
Clinical trial NCT06588660 · TERMINATED
Trial details
- NCT number
- NCT06588660
- Sponsor
- University of Washington
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-18
- Primary completion
- 2025-02-14
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.